Illumina (NASDAQ:ILMN) today introduced TruSeq Stranded mRNA and Total
RNA Sample Preparation Kits for RNA sequencing. The new reagent kits
enable researchers to quickly and easily conduct gene expression studies
that provide a complete view of the transcriptome, even from low-quality
RNA samples, such as formalin-fixed, paraffin-embedded (FFPE) samples.
The Total RNA Sample Preparation Kit efficiently removes ribosomal RNA
and other high abundance transcripts using Epicentre's proven Ribo-Zero™
ribosomal RNA reduction chemistry, with an improved workflow optimized
for high-throughput studies. The resulting combination of high-quality
ribosomal removal and sample preparation chemistries into a single,
streamlined solution provides an exciting new opportunity for
researchers to conduct highly-accurate gene expression studies.
"TruSeq Stranded mRNA and Total RNA Sample Preparation Kits offer
powerful, high-throughput, and easy-to-use reagent solutions suited to a
broad range of study designs, including those that use challenging but
important FFPE samples," said Christian Henry, Senior Vice President and
General Manager of Illumina's Genomic Solutions Business. "These types
of samples are a rich source of information on changes in gene
expression and regulation associated with cancer and a wide range of
other diseases."
The TruSeq Stranded RNA Sample Preparation Kits are available in
multiple configurations to suit a wide range of study design needs, with
offerings for both mRNA-focused and whole-transcriptome analysis, as
well as for both small and large sample sizes. Configurations compatible
with human, mouse and rat samples are currently available, with
additional offerings planned later this year for plant samples and for
the effective removal of globin transcripts from blood samples.